Aims To assess cytokine levels in peripheral blood and tears of patients after allogeneic haematopoietic stem cell ...

CancerBuddy connects users through shared diagnoses and experiences, offering community when hospital walls feel especially ...

The authors found comparable results among patients in all 3 donor categories. For instance, the 2-year overall survival (OS) ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products are manufactured from U.S ...

Picture this: you’re surviving cancer, chemotherapy, radiation, immunosuppression, and a blood stem cell transplant, and you haven’t left the hospital in weeks. Yet, somehow, you have what feels and ...

Imminent launch of grant-funded clinical trial in graft-versus-host disease (GVHD)Advancing clinical program in severe pulmonary inflammatory ...

This article explores how stem cell therapies and organoid models are advancing Alzheimer’s research. It highlights progress ...

The U.S. Department of Energy's National Nuclear Security Administration has removed Cesium-137 Irradiators from medical facilities across the country over concerns that they could be used to create ...

Damien Thompson is no stranger to hospital beds, having spent the last 15 years receiving treatment on and off after he was ...

When Sherry received a diagnosis of endometrial cancer, her life was forever changed. Learn more about her journey.

Jack Ricketts sadly left behind a devastated fiancé and three-year-old daughter as he was placed into a coma and died last ...

Positive results from Phase 3 trial for MaaT013 in acute Graft-versus-Host disease (aGvHD); topline results showed a 62% gastrointestinal overall response rate at Day 28 and 1-year expected Overall ...